📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Zionexa

1.1 - Company Overview

Zionexa Logo

Zionexa

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of in-vivo biomarkers developed and commercialized to guide targeted therapies in oncology, aiming to improve patients' pathway and quality of life.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Zionexa

Atara Biotherapeutics Logo

Atara Biotherapeutics

HQ: United States Website
  • Description: Provider of off-the-shelf, allogeneic T-cell immunotherapies, conducting clinical studies to evaluate safety and efficacy; offering expanded access to investigational drugs for treatment use; providing educational grants in T-cell immunotherapy; and supplying healthcare providers with information on products and clinical application.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Atara Biotherapeutics company profile →
Koelis Logo

Koelis

HQ: France Website
  • Description: Provider of medical imaging solutions for urologists, including KOELIS Trinity MRI/US prostate biopsy system for accurate needle guidance in prostate cancer diagnosis and treatment; OBT Fusion for prostate tracking and core location recording with precise targeting; 3D Ultrasound with motion compensation; 2nd Look Option; and transperineal and transrectal tools with 3D probes, holders, guides, and accessories.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Koelis company profile →
Viome Life Sciences Logo

Viome Life Sciences

HQ: United States Website
  • Description: Provider of scientific discovery, research, and development services for health and chronic disease, offering RNA-based consumer analyses for health insights and precision nutrition, and advancing prediction, precision diagnostics, and therapeutics for chronic diseases, cancer, and aging, with RNA sequencing tests including gut microbiome, human gene expression, saliva, and vaginal.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Viome Life Sciences company profile →
Cero Therapeutics Logo

Cero Therapeutics

HQ: United States Website
  • Description: Provider of cellular immunotherapy centered on a CER T-cell platform that integrates anti-tumor capabilities of the innate and adaptive immune systems into a single T cell, aimed at treating hematologic malignancies and solid tumors.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cero Therapeutics company profile →
Point Biopharma Logo

Point Biopharma

HQ: United States Website
  • Description: Provider of radioligand therapies for cancer, with a globally focused platform for the clinical development and commercialization of radioligands. Combines a portfolio of radiopharmaceutical assets with a seasoned management team and expertise in radioisotopes.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Point Biopharma company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Zionexa

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Zionexa

2.2 - Growth funds investing in similar companies to Zionexa

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Zionexa

4.2 - Public trading comparable groups for Zionexa

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Zionexa

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Zionexa

What does Zionexa do?

Zionexa is a provider of in-vivo biomarkers developed and commercialized to guide targeted therapies in oncology, aiming to improve patients' pathway and quality of life.

Who are Zionexa's competitors?

Zionexa's competitors and similar companies include Atara Biotherapeutics, Koelis, Viome Life Sciences, Cero Therapeutics, and Point Biopharma.

Where is Zionexa headquartered?

Zionexa is headquartered in United States.

How many employees does Zionexa have?

Zionexa has 1,000 employees 🔒.

When was Zionexa founded?

Zionexa was founded in 2010 🔒.

What sector and industry vertical is Zionexa in?

Zionexa is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Zionexa

Who are the top strategic acquirers in Zionexa's sector and industry

Top strategic M&A buyers and acquirers in Zionexa's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Zionexa?

Top strategic M&A buyers groups and sectors for Zionexa include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Zionexa's sector and industry vertical

Which are the top PE firms investing in Zionexa's sector and industry vertical?

Top PE firms investing in Zionexa's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Zionexa's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Zionexa's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Zionexa's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Zionexa include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Zionexa's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Zionexa?

The key public trading comparables and valuation benchmarks for Zionexa include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Zionexa for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Zionexa with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Zionexa's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Zionexa with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Zionexa's' sector and industry vertical?

Access recent funding rounds and capital raises in Zionexa's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Zionexa